17 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
to be immaterial, could materially and adversely affect our business, financial condition, results of operations and prospects, and reputation … , unexpected characteristics, or other SAEs occur, our clinical trials could be suspended or terminated, and our business and reputation could suffer
ARS
mbhsay5fzej 087fjoa
28 Apr 23
Annual report to shareholders
12:00am
DEF 14A
tfzdhaan
11 Aug 22
Definitive proxy
4:04pm
10-K
vd0dm1aw09jyd u92wz
21 Mar 22
Annual report
4:19pm
8-K
EX-10.1
h5qe97g6vd9e3g0
19 Jan 22
Entry into a Material Definitive Agreement
4:19pm
424B4
euksf
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
vqu2w5x415mv0
19 Jul 21
IPO registration (amended)
6:09am
S-1
c8mmiqkj70
1 Jul 21
IPO registration
4:05pm
S-1
EX-10.26
6ck9jc
1 Jul 21
IPO registration
4:05pm
DRS/A
jv0ym
11 Jun 21
Draft registration statement (amended)
12:00am
DRS
6dxi15fbaesgjk sc8
7 May 21
Draft registration statement
12:00am
DRS
EX-10.23
mfq9j pie70
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next